50
Participants
Start Date
December 12, 2018
Primary Completion Date
August 20, 2019
Study Completion Date
April 30, 2020
TFV/LNG IVR
TFV/LNG IVR is an intravaginal ring that releases approximately 8-10 mg/day of TFV and approximately 20ug/day of LNG to be used for 90 continuous days.
TFV IVR
TFV IVR is an intravaginal ring that releases approximately 8-10mg/day of TFV to be used for 90 continuous days.
Placebo IVR
Placebo IVR is an intravaginal ring containing no active experimental ingredients to be used for 90 continuous days.
Kenya Medical Research Institute, Center for Global Health Research, Kisumu
Collaborators (1)
Kenya Medical Research Institute
OTHER
University of Washington
OTHER
Centers for Disease Control and Prevention
FED
CONRAD
OTHER